These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 6751984

  • 41. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H, Villard-Mackintosh L, Vessey M, Yeates D, McPherson K.
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [Abstract] [Full Text] [Related]

  • 42. Short notes on intrauterine devices.
    Indian J Med Sci; 1990 May; 44(5):129-33. PubMed ID: 2397950
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Bacterial cultures from intrauterine devices removed from patients with pelvic inflammatory disease.
    Nilsson CG, Vartiainen E, Widholm O.
    Acta Obstet Gynecol Scand; 1981 May; 60(6):563-6. PubMed ID: 7039215
    [Abstract] [Full Text] [Related]

  • 45. IUDs and PID: understanding the American situation.
    Netw Res Triangle Park N C; 1987 May; 8(2):8. PubMed ID: 12268660
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease.
    Kaufman DW, Watson J, Rosenberg L, Helmrich SP, Miller DR, Miettinen OS, Stolley PD, Shapiro S.
    JAMA; 1983 Aug 12; 250(6):759-62. PubMed ID: 6876331
    [Abstract] [Full Text] [Related]

  • 48. Actinomycins and intrauterine contraceptive devices: the clinicopathologic study.
    Schmidt WA, Bedrossian CW, Ali V, Webb JA, Bastian FO.
    Diagn Gynecol Obstet; 1980 Aug 12; 2(3):165-77. PubMed ID: 7439012
    [Abstract] [Full Text] [Related]

  • 49. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM, Trobough GE.
    Am J Obstet Gynecol; 1986 Mar 12; 154(3):497-503. PubMed ID: 3513579
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device--related disorders.
    Kahn HS, Tyler CW.
    Am J Obstet Gynecol; 1976 May 01; 125(1):83-6. PubMed ID: 1275008
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The Dalkon Shield debate.
    Goodhue PA.
    Conn Med; 1983 Mar 01; 47(3):138-41. PubMed ID: 6851548
    [Abstract] [Full Text] [Related]

  • 56. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review.
    Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM.
    Contraception; 2013 May 01; 87(5):611-24. PubMed ID: 23177264
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.
    Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM.
    Contraception; 2013 May 01; 87(5):655-60. PubMed ID: 23040135
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.